{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:15:37Z","timestamp":1793121337704,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T00:00:00Z","timestamp":1647820800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.neo.2022.100791","type":"journal-article","created":{"date-parts":[[2022,4,8]],"date-time":"2022-04-08T12:37:12Z","timestamp":1649421432000},"page":"100791","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Regulation of growth, invasion and metabolism of breast ductal carcinoma through CCL2\/CCR2 signaling interactions with MET receptor tyrosine kinases"],"prefix":"10.1016","volume":"28","author":[{"given":"Diana Sof\u00eda","family":"Acevedo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei Bin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6934-6021","authenticated-orcid":false,"given":"Vinamratha","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vedha","family":"Penmetcha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Leyva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Acosta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige","family":"Cote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Brodine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Swerdlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0385-7774","authenticated-orcid":false,"given":"Philip L","family":"Lorenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikki","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2022.100791_bib0001","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41416-019-0478-6","article-title":"Ductal carcinoma in situ: to treat or not to treat, that is the question","volume":"121","author":"van Seijen","year":"2019","journal-title":"Br J Cancer"},{"key":"10.1016\/j.neo.2022.100791_bib0002","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12609-020-00363-2","article-title":"Ductal carcinoma in situ (DCIS): the importance of patient-reported outcomes (PRO)","volume":"12","author":"Dominici","year":"2020","journal-title":"Current breast cancer reports"},{"key":"10.1016\/j.neo.2022.100791_bib0003","first-page":"662","volume":"28","author":"Sanders","year":"2015","journal-title":"Inc"},{"key":"10.1016\/j.neo.2022.100791_bib0004","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","article-title":"Triple-negative breast cancer molecular subtyping and treatment progress","volume":"22","author":"Yin","year":"2020","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.neo.2022.100791_bib0005","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41523-020-0167-x","article-title":"Contrasting DCIS and invasive breast cancer by subtype suggests basal-like DCIS as distinct lesions","volume":"6","author":"Bergholtz","year":"2020","journal-title":"NPJ Breast Cancer"},{"key":"10.1016\/j.neo.2022.100791_bib0006","doi-asserted-by":"crossref","first-page":"4054","DOI":"10.1158\/1078-0432.CCR-19-1152","article-title":"Validation of a ductal carcinoma in situ biomarker profile for risk of recurrence after breast-conserving surgery with and without radiotherapy","volume":"26","author":"Weinmann","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.neo.2022.100791_bib0007","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/PAI.0000000000000223","article-title":"Her2 and Ki67 biomarkers predict recurrence of ductal carcinoma in situ","volume":"24","author":"Davis","year":"2016","journal-title":"Appl Immunohistochem Mole Morphol AIMM \/Off Publ Soc Appl Immunohistochem"},{"key":"10.1016\/j.neo.2022.100791_bib0008","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/bs.acr.2016.05.005","article-title":"Cytokine regulation of metastasis and tumorigenicity","volume":"132","author":"Yao","year":"2016","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.neo.2022.100791_bib0009","doi-asserted-by":"crossref","first-page":"28697","DOI":"10.18632\/oncotarget.7376","article-title":"Targeting the CCL2-CCR2 signaling axis in cancer metastasis","volume":"7","author":"Lim","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.neo.2022.100791_bib0010","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.771210","article-title":"Targeting the CCL2\/CCR2 axis in cancer immunotherapy: one stone, three birds?","volume":"12","author":"Fei","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.neo.2022.100791_bib0011","doi-asserted-by":"crossref","first-page":"36593","DOI":"10.1074\/jbc.M112.365999","article-title":"CCL2\/CCR2 chemokine signaling coordinates survival and motility of breast cancer cells through Smad3 protein- and p42\/44 mitogen-activated protein kinase (MAPK)-dependent mechanisms","volume":"287","author":"Fang","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neo.2022.100791_bib0012","doi-asserted-by":"crossref","first-page":"8708","DOI":"10.1038\/s41598-021-88229-0","article-title":"Expression of CCL2\/CCR2 signaling proteins in breast carcinoma cells is associated with invasive progression","volume":"11","author":"Fang","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.neo.2022.100791_bib0013","doi-asserted-by":"crossref","first-page":"R66","DOI":"10.1186\/bcr2358","article-title":"An intraductal human-in-mouse transplantation model mimics the subtypes of ductal carcinoma in situ","volume":"11","author":"Behbod","year":"2009","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.neo.2022.100791_bib0014","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/path.2969","article-title":"Human primary ductal carcinoma in situ (DCIS) subtype-specific pathology is preserved in a mouse intraductal (MIND) xenograft model","volume":"225","author":"Valdez","year":"2011","journal-title":"J Pathol"},{"key":"10.1016\/j.neo.2022.100791_bib0015","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1158\/1541-7786.MCR-17-0308","article-title":"Chemokine signaling facilitates early-stage breast cancer survival and invasion through fibroblast-dependent mechanisms","volume":"16","author":"Brummer","year":"2018","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.neo.2022.100791_bib0016","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132285","article-title":"Inhibition of aerobic glycolysis represses Akt\/mTOR\/HIF-1alpha axis and restores tamoxifen sensitivity in antiestrogen-resistant breast cancer cells","volume":"10","author":"Woo","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neo.2022.100791_bib0017","doi-asserted-by":"crossref","first-page":"5425","DOI":"10.1073\/pnas.1501555112","article-title":"Metabolic reprogramming in triple-negative breast cancer through Myc suppression of TXNIP","volume":"112","author":"Shen","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neo.2022.100791_bib0018","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.yexcr.2011.11.014","article-title":"Lactate is a mediator of metabolic cooperation between stromal carcinoma associated fibroblasts and glycolytic tumor cells in the tumor microenvironment","volume":"318","author":"Rattigan","year":"2012","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.neo.2022.100791_bib0019","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1111\/cas.12238","article-title":"Hexokinase II in breast carcinoma: a potent prognostic factor associated with hypoxia-inducible factor-1alpha and Ki-67","volume":"104","author":"Sato-Tadano","year":"2013","journal-title":"Cancer Science"},{"key":"10.1016\/j.neo.2022.100791_bib0020","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2011342118","article-title":"The harsh microenvironment in early breast cancer selects for a Warburg phenotype","volume":"118","author":"Damaghi","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neo.2022.100791_bib0021","doi-asserted-by":"crossref","first-page":"11954","DOI":"10.1038\/s41598-020-68769-7","article-title":"Chemokine C-C motif ligand 2 overexpression drives tissue-specific metabolic responses in the liver and muscle of mice","volume":"10","author":"Luciano-Mateo","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.neo.2022.100791_bib0022","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/jnci\/92.14.1185a","article-title":"MCF10DCIS.com xenograft model of human comedo ductal carcinoma in situ","volume":"92","author":"Miller","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.neo.2022.100791_bib0023","first-page":"2831","article-title":"Receptor status and subsequent sensitivity of subclones of MCF-7 human breast cancer cells surviving exposure to diethylstilbestrol","volume":"43","author":"Brandes","year":"1983","journal-title":"Cancer Res"},{"key":"10.1016\/j.neo.2022.100791_bib0024","first-page":"3237","article-title":"Characterization of a breast cancer cell line derived from a germ-line BRCA1 mutation carrier","volume":"58","author":"Tomlinson","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.neo.2022.100791_bib0025","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s10637-017-0545-x","article-title":"MET-targeting antibody (emibetuzumab) and kinase inhibitor (merestinib) as single agent or in combination in a cancer model bearing MET exon 14 skipping","volume":"36","author":"Yan","year":"2018","journal-title":"Investig New Drugs"},{"key":"10.1016\/j.neo.2022.100791_bib0026","article-title":"Role of ALDH1A1 and HTRA2 expression in CCL2\/CCR2-mediated breast cancer cell growth and invasion","volume":"8","author":"Hu","year":"2019","journal-title":"Biol Open"},{"key":"10.1016\/j.neo.2022.100791_bib0027","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nbt.3437","article-title":"Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9","volume":"34","author":"Doench","year":"2016","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.neo.2022.100791_bib0028","doi-asserted-by":"crossref","first-page":"49349","DOI":"10.18632\/oncotarget.9885","article-title":"Targeted gene silencing of CCL2 inhibits triple negative breast cancer progression by blocking cancer stem cell renewal and M2 macrophage recruitment","volume":"7","author":"Fang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.neo.2022.100791_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2018.12.043","article-title":"Functional genomics reveals synthetic lethality between phosphogluconate dehydrogenase and oxidative phosphorylation","volume":"26","author":"Sun","year":"2019","journal-title":"Cell Rep"},{"key":"10.1016\/j.neo.2022.100791_bib0030","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov"},{"key":"10.1016\/j.neo.2022.100791_bib0031","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal"},{"key":"10.1016\/j.neo.2022.100791_bib0032","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1158\/1541-7786.MCR-18-0750","article-title":"CCR2 chemokine receptors enhance growth and cell-cycle progression of breast cancer cells through SRC and PKC activation","volume":"17","author":"Yao","year":"2019","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.neo.2022.100791_bib0033","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1023\/A:1018790705727","article-title":"Roles of hepatocyte growth factor\/scatter factor and transforming growth factor-beta1 in mammary gland ductal morphogenesis","volume":"3","author":"Soriano","year":"1998","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"10.1016\/j.neo.2022.100791_bib0034","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1242\/dev.121.9.2897","article-title":"HGF\/SF: a potent cytokine for mammary growth, morphogenesis and development","volume":"121","author":"Niranjan","year":"1995","journal-title":"Development"},{"key":"10.1016\/j.neo.2022.100791_bib0035","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13058-015-0547-6","article-title":"The clinical and functional significance of c-Met in breast cancer: a review","volume":"17","author":"Ho-Yen","year":"2015","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.neo.2022.100791_bib0036","doi-asserted-by":"crossref","first-page":"42319","DOI":"10.1038\/srep42319","article-title":"PARP inhibitor increases chemosensitivity by upregulating miR-664b-5p in BRCA1-mutated triple-negative breast cancer","volume":"7","author":"Song","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.neo.2022.100791_bib0037","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1186\/1471-2407-14-418","article-title":"B-cell lymphoma 6 protein stimulates oncogenicity of human breast cancer cells","volume":"14","author":"Wu","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/j.neo.2022.100791_bib0038","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/jcb.22219","article-title":"Src and FAK mediate cell-matrix adhesion-dependent activation of Met during transformation of breast epithelial cells","volume":"107","author":"Hui","year":"2009","journal-title":"J Cell Biochem"},{"key":"10.1016\/j.neo.2022.100791_bib0039","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1158\/1078-0432.CCR-10-1617","article-title":"Distinct interactions between c-Src and c-Met in mediating resistance to c-Src inhibition in head and neck cancer","volume":"17","author":"Sen","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.neo.2022.100791_bib0040","doi-asserted-by":"crossref","first-page":"7597","DOI":"10.18632\/oncotarget.3162","article-title":"Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer","volume":"6","author":"Kim","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.neo.2022.100791_bib0041","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.coemr.2020.10.003","article-title":"Transactivation of G protein-coupled receptors (GPCRs) and receptor tyrosine kinases (RTKs): recent insights using luminescence and fluorescence technologies","volume":"16","author":"Kilpatrick","year":"2021","journal-title":"Curr Opin Endocr Metab Res"},{"key":"10.1016\/j.neo.2022.100791_bib0042","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/nn.2216","article-title":"FGF acts as a co-transmitter through adenosine A(2A) receptor to regulate synaptic plasticity","volume":"11","author":"Flajolet","year":"2008","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.neo.2022.100791_bib0043","first-page":"2940","article-title":"Met receptor tyrosine kinase signals through a cortactin-Gab1 scaffold complex, to mediate invadopodia","volume":"125","author":"Rajadurai","year":"2012","journal-title":"J Cell Sci"},{"key":"10.1016\/j.neo.2022.100791_bib0044","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2119\/2007-00101.YU","article-title":"Differential expression of receptor tyrosine kinases (RTKs) and IGF-I pathway activation in human uterine leiomyomas","volume":"14","author":"Yu","year":"2008","journal-title":"Mol Med"},{"key":"10.1016\/j.neo.2022.100791_bib0045","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1093\/carcin\/22.9.1363","article-title":"Hepatocyte growth factor signalling stimulates hypoxia inducible factor-1 (HIF-1) activity in HepG2 hepatoma cells","volume":"22","author":"Tacchini","year":"2001","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.neo.2022.100791_bib0046","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/s12943-019-1089-9","article-title":"Role of hypoxia in cancer therapy by regulating the tumor microenvironment","volume":"18","author":"Jing","year":"2019","journal-title":"Mol Cancer"},{"key":"10.1016\/j.neo.2022.100791_bib0047","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14030553","article-title":"Advancing cancer treatment by targeting glutamine metabolism-a roadmap","volume":"14","author":"Halama","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.neo.2022.100791_bib0048","doi-asserted-by":"crossref","DOI":"10.3390\/cells8101225","article-title":"Transcriptional regulation of energy metabolism in cancer cells","volume":"8","author":"Rodriguez-Enriquez","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.neo.2022.100791_bib0049","doi-asserted-by":"crossref","first-page":"5997","DOI":"10.1038\/s41388-018-0386-x","article-title":"PIM2-mediated phosphorylation of hexokinase 2 is critical for tumor growth and paclitaxel resistance in breast cancer","volume":"37","author":"Yang","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.neo.2022.100791_bib0050","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.coisb.2017.11.005","article-title":"New concepts in feedback regulation of glucose metabolism","volume":"8","author":"Locasale","year":"2018","journal-title":"Curr Opin Syst Biol"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558622000203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558622000203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T13:10:03Z","timestamp":1761484203000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558622000203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":50,"alternative-id":["S1476558622000203"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2022.100791","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regulation of growth, invasion and metabolism of breast ductal carcinoma through CCL2\/CCR2 signaling interactions with MET receptor tyrosine kinases","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2022.100791","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100791"}}